SEC Form 4 · accession 0001209191-17-042350
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric David
Officer — CSO & EVP Pre-Clinical Dev
Period of report
Jun 27, 2017
Accepted (ET)
Jun 29, 2017 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 27, 2017 | A | 190,000 | $0.00 | A | 890,703 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors.
- F2The shares represent a grant of Restricted Stock Units ("RSUs"). The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price. The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2017.
- F3This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,960,703 shares of common stock.